Cargando…

Oncogenic Kras-Mediated Cytokine CCL15 Regulates Pancreatic Cancer Cell Migration and Invasion through ROS

SIMPLE SUMMARY: Oncogenic Kras(G12D) and tumor inflammation are critical components of the development and dissemination of pancreatic ductal adenocarcinoma (PDAC). The aim of this study is to investigate a lesser-known cytokine, CCL15, that functions as a new downstream target of Kras(G12D) with th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messex, Justin K., Adams, Kiyah L. A., Hawkins, William G., DeNardo, David, Bardeesy, Nabeel, Billadeau, Daniel D., Liou, Geou-Yarh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104113/ https://www.ncbi.nlm.nih.gov/pubmed/35565279 http://dx.doi.org/10.3390/cancers14092153

Ejemplares similares

Targeting BTK Signaling in the Microenvironment of Solid Tumors as a Feasible Cancer Therapy Option
por: Messex, Justin K., et al.
Publicado: (2021)

Impact of Immune Cells in the Tumor Microenvironment of Prostate Cancer Metastasis
por: Messex, Justin K., et al.
Publicado: (2023)

Macrophages Cytokine Spp1 Increases Growth of Prostate Intraepithelial Neoplasia to Promote Prostate Tumor Progression
por: Messex, Justin K., et al.
Publicado: (2022)

Signaling of Macrophages that Contours the Tumor Microenvironment for Promoting Cancer Development
por: Messex, Justin K., et al.
Publicado: (2020)

Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers
por: Liou, Geou-Yarh
Publicado: (2017)

Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt
por: Dang, Tu, et al.
Publicado: (2018)

Inflammatory macrophages in pancreatic acinar cell metaplasia and initiation of pancreatic cancer
por: Liou, Geou-Yarh, et al.
Publicado: (2015)

Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need
por: Liou, Geou-Yarh, et al.
Publicado: (2023)

Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity
por: Döppler, Heike, et al.
Publicado: (2013)

Generation of Hydrogen Peroxide and Downstream Protein Kinase D1 Signaling Is a Common Feature of Inducers of Pancreatic Acinar-to-Ductal Metaplasia
por: Döppler, Heike R., et al.
Publicado: (2022)

Nuclear GSK-3β and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN
por: Ding, Li, et al.
Publicado: (2022)

Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs
por: Liou, Geou-Yarh, et al.
Publicado: (2013)

NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation
por: Hessmann, Elisabeth, et al.
Publicado: (2016)

Inflammatory and alternatively activated macrophages independently induce metaplasia but cooperatively drive pancreatic precancerous lesion growth
por: Liou, Geou-Yarh, et al.
Publicado: (2023)

Battle over CCL2 for control of the metastatic niche: neutrophils versus monocytes
por: Mitchem, Jonathan B, et al.
Publicado: (2012)

Ym1(+) macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer
por: Fleming Martinez, Alicia K., et al.
Publicado: (2022)

Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels
por: Kong, Bo, et al.
Publicado: (2013)

Dysfunctional EGFR and oxidative stress-induced PKD1 signaling drive formation of DCLK1+ pancreatic stem cells
por: Fleming Martinez, Alicia K., et al.
Publicado: (2021)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca(2+) signals that are inhibited by oncogenic KRas
por: Pratt, Stephen J. P., et al.
Publicado: (2020)

KRAS-driven ROS promote malignant transformation
por: Suh, Yongjoon, et al.
Publicado: (2015)

Immune modulatory effects of oncogenic KRAS in cancer
por: Hamarsheh, Shaima’a, et al.
Publicado: (2020)

Targeting the undruggable oncogenic KRAS: the dawn of hope
por: Asimgil, Hande, et al.
Publicado: (2022)

Conquering oncogenic KRAS and its bypass mechanisms
por: Hou, Pingping, et al.
Publicado: (2022)

Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
por: Sabnis, Amit J, et al.
Publicado: (2009)

Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
por: Collins, Meredith A., et al.
Publicado: (2012)

Oncogenic KRAS promotes malignant brain tumors in zebrafish
por: Ju, Bensheng, et al.
Publicado: (2015)

Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
por: Liu, Xinquan, et al.
Publicado: (2019)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
por: Strand, Matthew S., et al.
Publicado: (2019)

Endothelial cell-derived CCL15 mediates the transmigration of fibrocytes through the CCL15-CCR1 axis in vitro
por: Pang, Nan, et al.
Publicado: (2020)

Kras as a key oncogene and therapeutic target in pancreatic cancer
por: Collins, Meredith A., et al.
Publicado: (2014)

The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)

Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype
por: Fu, Yong, et al.
Publicado: (2015)

KRAS insertion mutations are oncogenic and exhibit distinct functional properties
por: White, Yasmine, et al.
Publicado: (2016)

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)

Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer
por: Kamerkar, Sushrut, et al.
Publicado: (2017)

Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
por: Tang, Daolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jltq9pu7fuqg0sqh4ve23nkqt4